InMed Pharmaceuticals Inc. INM
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -5.54M | -7.66M | -8.21M | -8.16M |
| Total Depreciation and Amortization | -- | 443.40K | 573.00K | 544.10K | 532.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -575.90K | -509.50K | -568.50K | -555.90K |
| Change in Net Operating Assets | -- | -418.80K | -153.40K | 355.50K | 86.30K |
| Cash from Operations | -- | -6.09M | -7.75M | -7.88M | -8.10M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 3.77M | 6.70M | 7.10M | 8.13M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 4.27M | 4.25M | 4.20M | 4.14M |
| Cash from Financing | -- | 8.04M | 10.96M | 11.30M | 12.27M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 1.94M | 3.20M | 3.42M | 4.17M |